|
Week - 1
|
|
Introduction to pharmacology and its functional role in the pharmacy, knowledge of homeostasis, description of disease state, general characteristics of progressive and non-progressive diseases |
|
|
Week - 2
|
|
Description of drug concept, types of therapy and pharmacotherapy: descriptive differences between radical, symptomatic and palliative therapies, subdivisions of pharmacology: pharmacodynamics, pharmacokinetics, etc. |
|
|
Week - 3
|
|
Phases of a new drug development: preclinical phase, clinical phases (phase I, II, III and IV studies), safety studies, pharmacovigilance, post-marketing surveillance, importance of pharmacoepidemiological surveys |
|
|
Week - 4
|
|
Mechanisms of drug action:Non-specific and specific mechanisms (sites of action for drugs), receptors, ion channels, ion pumps, enzymes, pharmacodynamic interactions |
|
|
Week - 5
|
|
Drug receptors: Receptor theories, structures of receptors and their structural types, receptor biosynthesis and turnovers, drugs affecting receptors, Ion channels: Ion channel types and affecting drugs |
|
|
Week - 6
|
|
Drug receptors: Receptor theories, structures of receptors and their structural types, receptor biosynthesis and turnovers, drugs affecting receptors, Ion channels: Ion channel types and affecting drugs |
|
|
Week - 7
|
|
Explanation of the in vitro research techniques used in new drug development. |
|
|
Week - 8
|
|
Explanation of the in vivo research techniques used in new drug development. |
|
|
Week - 9
|
|
Used in the experiments give information about animals and ethical guidelines must be followed. |
|
|
Week - 10
|
|
Give information about blood pressure measurement methods . |
|
|
Week - 11
|
|
Explanation of behavioral experiment. |
|
|
Week - 12
|
|
Explanation of analgesic and anti-inflammatory test methods. |
|
|
Week - 13
|
|
Laboratory demonstration |
|
|
Week - 14
|
|
Laboratory demonstration |
|